RadNet, Inc. RDNT yesterday announced that its wholly-owned subsidiary, DeepHealth, Inc., has partnered with artificial ...

DeepHealth has launched new AI-powered solutions at RSNA 2024. These solutions enable breakthroughs in imaging-based diagnosis, population ...

DeepHealth's AI-powered informatics portfolio features the newly introduced Diagnostic Suite™ and TechLive™1, integrated ...

Truist Financial analyst David S Macdonald reiterated a Buy rating on Radnet (RDNT – Research Report) today and set a price target of $94.00. The company’s shares closed last Wednesday at $82.49.

Mutual of America Capital Management LLC cut its position in shares of RadNet, Inc. (NASDAQ:RDNT – Free Report) by 10.4% ...

Below is Validea's guru fundamental report for RADNET INC (RDNT). Of the 22 guru strategies we follow, RDNT rates highest using our Quantitative Momentum Investor model based on the published ...

DeepHealth and CARPL.ai have established a strategic collaboration to create a unique Artificial Intelligence (AI) control ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $83.25, ...

SmartMammo™’s AI algorithm now FDA cleared with GE HealthCare’s Senographe Pristina™, expanding access to enhanced cancer ...